Correlation Between Amplify and IShares Genomics
Can any of the company-specific risk be diversified away by investing in both Amplify and IShares Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amplify and IShares Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amplify and iShares Genomics Immunology, you can compare the effects of market volatilities on Amplify and IShares Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amplify with a short position of IShares Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amplify and IShares Genomics.
Diversification Opportunities for Amplify and IShares Genomics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Amplify and IShares is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Amplify and iShares Genomics Immunology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Genomics Imm and Amplify is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amplify are associated (or correlated) with IShares Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Genomics Imm has no effect on the direction of Amplify i.e., Amplify and IShares Genomics go up and down completely randomly.
Pair Corralation between Amplify and IShares Genomics
If you would invest (100.00) in Amplify on November 29, 2024 and sell it today you would earn a total of 100.00 from holding Amplify or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Amplify vs. iShares Genomics Immunology
Performance |
| Timeline |
| Amplify |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| iShares Genomics Imm |
Amplify and IShares Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amplify and IShares Genomics
The main advantage of trading using opposite Amplify and IShares Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amplify position performs unexpectedly, IShares Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Genomics will offset losses from the drop in IShares Genomics' long position.| Amplify vs. iShares Genomics Immunology | Amplify vs. Direxion Work From | Amplify vs. Loncar Cancer Immunotherapy |
| IShares Genomics vs. Global X Genomics | IShares Genomics vs. iShares Cybersecurity and | IShares Genomics vs. iShares Self Driving EV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |